Purpose: It is unknown whether neurohospitalist evaluation improves door-to-needle times (DNT) in patients with acute ischemic stroke.The purpose of this study is to determine the impact of neurohospitalist evaluation on DNT for patients with ischemic stroke receiving intravenous tissue plasminogen activator (tPA) presenting within 4.5 hours of symptom onset. Methods: We retrospectively identified consecutive patients with ischemic stroke who received tPA between 0 and 4.5 hours. We determined and compared DNT for nonneurohospitalists versus neurohospitalists for a 26-month period from 2009 to 2011. Our main outcome measure was percentage of patients receiving tPA within 60 minutes. Results: Overall, out of the 107 consecutive ischemic stroke patients (mean age 67 years) who received intravenous tPA within 4.5 hours, 60 patients were evaluated by nonneurohospitalists (community and locums neurologists) and 47 patients were evaluated by neurohospitalists. Mean + standard deviation (SD) DNT with patients treated by nonneurohospitalists (93 + 24 minutes) were significantly longer than the DNT treated by neurohospitalists (68 + 18 minutes). Twenty-four patients (51%) treated by neurohospitalists had DNT less than or equal to 60 minutes, while 9 patients (15%) treated by nonneurohospitalists had DNT less than or equal to 60 minutes. Multivariate analysis showed that neurohospitalist evaluation (odds ratio [OR] 5.4, confidence interval [CI] 2.2-13.6, P ¼ .022) was the only independent factor associated with patients receiving tPA within 60 minutes. Conclusion: Neurohospitialist evaluation is associated with faster DNT in patients with ischemic stroke. Neurohospitalist evaluation could be a part of a multidimensional initiative to improve the timeliness of tPA administration.
Introduction
Patients with ischemic stroke benefit from intravenous tissue plasminogen activator (tPA), when given expeditiously. 1 Current best practice strategy identified by American Heart Association/American Stroke Association (AHA/ASA) sponsored Target: Stroke program is to achieve a door-to-needle time (DNT) 60 minutes for at least 50% of patients with acute ischemic stroke. However, less than one third of patients with acute ischemic stroke who receive tPA are treated within the guideline-recommended 60 minutes. 2 This program has identified 10 key strategies to improve DNT. These include emergency medical service prenotification, activating the stroke team with a single call, rapid acquisition and interpretation of brain imaging, use of specific protocols and tools, premixing tPA, a team-based approach, and rapid data feedback. Neurohospitalists are inpatient site-specific specialists mainly responsible for managing inpatient neurological conditions. 3 Community neurologists, who are chiefly outpatient based and periodically cover the hospital on call, may not have time or interest to focus on inpatient quality and safety metrics on top giving optimal care to their outpatient population. Neurohospitalist model has been associated with reduced length of stay in patients with ischemic stroke. 4 Limited data are available regarding whether inpatient neurohospitalist evaluation has an impact on DNT for intravenous thrombolysis in patients with ischemic stroke within 4.5 hours of symptom onset. We know that most inpatient neurologists are vascular neurologists. 2 But, there is no specific data comparing vascular neurologists and community neurologists on the quality of inpatient care. Our aim is to retrospectively compare DNT for intravenous thrombolysis in ischemic stroke between nonneurohospitalists and neurohospitalists at a single institution in the emergency department (ED).
Design/Methods
After Institutional Review Board (IRB) approval, we retrospectively identified consecutive patients with ischemic stroke who received intravenous tPA between 0 and 4. Prior to August 2010, community neurologists (total 4) were responsible for a primary consultative inpatient service maintained by a rotating schedule. They also shared clinical responsibilities that included office hours in outpatient clinics along with inpatient care. Two neurohospitalists (primarily consultative) were hired by the hospital on August 15, 2010 (A.B. who is board certified in vascular neurology and A.S. who is board certified in clinical neurophysiology). Locums neurologists and community neurologists provided occasional weekend coverage. The primary task of the neurohospitalists was to provide care for neurological patients admitted to the hospital or ED at 2 hospitals; Butterworth hospital which has 701 beds and Blodgett hospital which has 280 beds. Patients were not admitted in the stroke unit. The DNT were collected from time of triage to time of intravenous tPA bolus administration, which was expressed in minutes. A multidisciplinary team, which included ED physicians, pharmacists, neurologists, radiologists, were involved in any ''code stroke'' evaluation in the ED and was responsible for doing the initial evaluation and completing the tPA inclusion/exclusion checklist based on the most current evidence. 5, 6 The on-call neurologist made the final decision regarding administration of tPA within 0 to 4.5 hours of symptom onset. The data that were retrospectively abstracted include demographic data, National Institute of Health Stroke Scale (NIHSS), DNT, door-to-inclusion/exclusion checklist completed time, door-to-computed tomography (CT) brain read by a radiologist time, door-to-laboratories known time and data pertaining to evidence of symptomatic intracranial (presence of intracranial hemorrhage on CT or magnetic resonance imaging with 3 point NIHSS deterioration within 36 hours), or any other life-threatening hemorrhage within 36 hours of admission, determined by predefined criteria. 5 In addition, we also collected data whether the on-call neurologist was physically present in the hospital when code stroke was activated. Data were stored in a computer database. Both A.B. and A.S. gathered the data in a blinded fashion.
The 95% confidence interval was calculated for the mean DNT for patients with ischemic stroke cared for by neurohospitalists and nonneurohospitalists. Continuous variables were compared with the independent samplest test and categorical variables were tested for association with chi-square test statistic. P value of <.05 was considered statistically significant. Our main outcome measure was percentage of patients receiving tPA within or equal to 60 minutes. We also compared compliance of AHA/ASA suggested best practice strategy to achieve a DNT 60 minutes for at least 50% of patients with acute ischemic stroke and rates of symptomatic intracranial or life threatening hemorrhage between the 2 groups. In a multivariate model, factors such as age, sex, door-to-CT brain time, door-tolaboratories known time, door-to-inclusion/exclusion checklist completion time, and whether neurologist was physically present in the hospital when code stroke called were analyzed.
Results
A total of 789 patients were evaluated by nonneurohospitalists and 484 patients by neurohospitalists over a 26-month period. The overall tPA rate is 8.7%. Of the 107 consecutive patients with ischemic stroke (mean age 67 years) who received intravenous tPA within 4.5 hours, 60 patients were evaluated by nonneurohospitalists and 47 patients were evaluated by neurohospitalists. The baseline data are summarized in Table 1 . Mean + SD DNT with patients treated by nonneurohospitalists (93 + 24 minutes) were significantly longer (P ¼ .031) than the DNT treated by neurohospitalists (68 + 18 minutes). Twenty-four (51%) patients treated by neurohospitalists had DNT less than or equal to 60 minutes, while 9 patients (15%) patients treated by nonneurohospitalists had DNT less than or equal to 60 minutes. Symptomatic intracranial bleed rate was lower in patients treated by neurohospitalists compared to non-neurohospitalists (2% vs 8%, P ¼ .061) but not statistically significant. A total of 4 protocol violations were observed. None of the patients had intracranial or lifethreatening bleeds. All violations were pertaining to blood pressure control after tPA administration. One was in the neurohospitalist group and 3 in the nonneurohospitialist group. The differences were not statistically significant (P ¼ .09). The in hospital mortality rate for patients receiving tPA was 2% (1 of 47) in the neurohospitalist group and 7% (4 of 60) in the nonneurohospitalist group. The difference was not statistically significant (P ¼ .07). Median length of stay for patients receiving tPA in neurohospitalist group was 4.2 + 1.1 days and 4.5 + 1.2 days in the nonneurohospitalist group. The difference was not significant statistically. The data pertaining to discharge disposition and thrombectomy and intra-arterial therapy rates are not available. Although not statistically significant, tPA administration rates were not different. Neurohospitalists were more likely to be present in the hospital when code stroke was activated as compared to nonneurohospitalists (80% vs 53%, P ¼ .017).
In a multivariate model (Table 2) , inpatient neurohospitalist evaluation (odds ratio [OR] 5.4, confidence interval [CI] 2.4-10.1, P < .022) and door-to-checklist completion time (OR 6.2, CI 1.7 -19.6, p ¼ .03) were the only independent factors associated with patients receiving tPA within 60 minutes. Mean time to complete the inclusion/exclusion checklist was significantly shorter when neurohospitalist evaluated the patient as compared to a nonneurohospitalist (44 + 6 vs 74 + 14 minutes, P ¼ .038).
Discussion
Each minute, 1.9 million neurons, 14 billion synapses, and 12 km (7.5 miles) of myelinated fibers are destroyed during an ischemic stroke. 7 In patients with ischemic stroke, thrombolytic treatment within 4.5 hours is time sensitive and early treatment with TPA yields better outcomes. 1 In our study, neurohospitalists achieved a significantly higher compliance rate for giving tPA within 60 minutes to a patient with ischemic stroke presenting to the ED. This strategy is recommended by AHA/ASA for at least 50% of patients with acute ischemic stroke. 2 As neurohospitalists do not have any outpatient responsibilities, they are more prompt and efficient in responding to ED stroke calls. [8] [9] [10] Our research also suggests that neurohospitalists were more likely to be physically present in the hospital when stroke code was called as compared to nonneurohospitalists. Patients who were cared by neurohospitalists had faster tPA checklist completion times. Neurohospitalists were more likely to complete exclusion inclusion tPA checklist within 45 minutes. These findings indicate that neurohospitalists may be more efficient in utilizing ''systems of care. '' 11 Our data also showed no statistically significant differences in tPA rates (9.7% vs 7.6%, P ¼ .051) and hemorrhage rates (2% vs 8%, P ¼ .061) among neurohospitalists as compared to nonneurohospitalists. Our research study is limited by a small sample size in a single institution and presence of only 2 neurohospitalists. Also, our data lacks long-term outcome data, for example Modified Rankin Scale at 3 months or 1 year. But this study provides real world estimates over a course of a 2-year period, where neurohospitalist evaluation was associated with faster DNT. This emphasizes that large tertiary care stroke centers where community neurologists are overwhelmed by outpatients and inpatient responsibilities should consider establishing neurohospitalist programs. This may be even more important as comprehensive stroke center guidelines emerge. 12 In our study, differences in DNT may be independently impacted by presence of a vascular neurologist (Table 3) as 64% of the tPAs administrated by the vascular neurologist were within 60 minutes as compared to 38% by the nonvascular neurologist hospitalist. But we believe this represents a real-world scenario where nonvascular neurologists work as neurohospitalist physicians. The differences in DNT may also reflect generational gap as both neurohospitalists were less than 35 years in age and all community neurologists were more than 35 years, although only 1 community neurologist was more than 50 years of age.
To our knowledge, this is the first study providing evidence that neurohospitalists are more likely to adhere to the guideline recommended 60 minutes for administration of intravenous tPA in patients with ischemic stroke in the ED. Larger studies comparing hospitals systems with different models (neurohospitalist vs nonneurohospitalist) could be performed. If confirmed, neurohospitalist evaluation could be a part of a multipronged effort to improve the timeliness of tPA administration. 
